Track XOMA Corporation — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

XOMA Corporation XOMAP · Stock Open XOMA Corporation in new tab

24.98 USD
P/E
24.95
EPS
1.00
P/B
3.20
ROE
34.23
Beta
0.87
Loading chart...
Key Metrics
Earnings dateJuly 30, 2026
P/E24.95
EPS1.00
Book Value7.79
Price to Book3.20
Debt/Equity110.49
Growth
Revenue Growth-0.23%
Earnings Growth2.08%

DCF Valuation

Tweak assumptions to recompute fair value for XOMA Corporation (XOMAP)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

XOMA Corporation Logo XOMA Corporation Analysis (XOMAP)

United States Health Care Official Website Stock

Is XOMA Corporation a good investment? XOMA Corporation (XOMAP) is currently trading at 24.98 USD.

In terms of valuation, the stock trades at a P/E ratio of 24.95. This valuation is generally in line with the broader market.

Earnings Schedule: XOMA Corporation is expected to release its next earnings report on July 30, 2026.

Investor FAQ

Does XOMA Corporation pay a dividend?

No, it does not currently pay a dividend.

What asset class is XOMA Corporation?

XOMA Corporation is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be July 30, 2026. The company currently has a trailing EPS of 1.00.

Company Profile

XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States, Switzerland, the Asia Pacific, and Australia. It has a portfolio of economic rights to future potential milestone and royalty payments associated with commercial products and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to sponsors or developers; and acquires milestone and royalty revenue streams on late-stage clinical assets and commercial assets. It has a portfolio with various assets. The company was formerly known as XOMA Corporation and changed its name to XOMA Royalty Corporation in July 2024. XOMA Royalty Corporation was incorporated in 1981 and is headquartered in Emeryville, California. As of July 14, 2026, XOMA Royalty Corporation operates as a subsidiary of Ligand Pharmaceuticals Incorporated.

Exchange Ticker
NGM (Sweden) XOMAP
Trades
Dividend History paid per year (USD)
Historical Dividends
Year Total Dividends
2027
1.03 USD
April 15, 2027 (estimated) 0.4940
Jan. 15, 2027 (estimated) 0.5390
2026
2.16 USD
Oct. 15, 2026 (estimated) 0.5390
July 14, 2026 0.5391
April 15, 2026 0.5390
Jan. 15, 2026 0.5390
2025
2.16 USD
Oct. 15, 2025 0.5390
July 15, 2025 0.5390
April 15, 2025 0.5390
Jan. 15, 2025 0.5390
2024
2.16 USD
Oct. 15, 2024 0.5390
July 15, 2024 0.5390
April 15, 2024 0.5390
Jan. 16, 2024 0.5390
2023
2.16 USD
Oct. 16, 2023 0.5390
July 17, 2023 0.5390
April 17, 2023 0.5390
Jan. 17, 2023 0.5390
2022
2.16 USD
Oct. 17, 2022 0.5390
July 15, 2022 0.5390
April 15, 2022 0.5390
Jan. 18, 2022 0.5390
2021
1.80 USD
Oct. 15, 2021 0.5390
July 15, 2021 0.5390
April 15, 2021 0.7190
Upcoming Dividends
Name Payment Date Status Amount
XOMA Corporation Jul 14, 2026 0.53906 USD
XOMA Corporation Apr 15, 2026 0.539 USD
XOMA Corporation Jan 15, 2026 0.539 USD
XOMA Corporation Oct 15, 2025 0.539 USD
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion